254 related articles for article (PubMed ID: 25377649)
41. Protective immune barrier against hepatitis B is needed in individuals born before infant HBV vaccination program in China.
Yang S; Yu C; Chen P; Deng M; Cao Q; Li Y; Ren J; Xu K; Yao J; Xie T; Wang C; Cui Y; Ding C; Tian G; Wang B; Zhang X; Ruan B; Li L
Sci Rep; 2015 Dec; 5():18334. PubMed ID: 26655735
[TBL] [Abstract][Full Text] [Related]
42. Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination.
Lai MW; Lin TY; Tsao KC; Huang CG; Hsiao MJ; Liang KH; Yeh CT
Gastroenterology; 2012 Aug; 143(2):400-7. PubMed ID: 22580098
[TBL] [Abstract][Full Text] [Related]
43. [Evaluation on impact of hepatitis B vaccine integrated into routine immunization in the areas of Ministry of Health/Global Alliance for Vaccine and Immunization (GAVI) Cooperation Project P.R. China].
Cui FQ; Gong XH; Chen YS
Zhongguo Yi Miao He Mian Yi; 2009 Aug; 15(4):289-93. PubMed ID: 20077723
[TBL] [Abstract][Full Text] [Related]
44. [Study on the effects of timely initiation and completion of hepatitis B vaccine on hepatitis B on virus prevention in Fujian, China].
Wu J; Yong Z; Huang L; He A
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Apr; 35(4):471-2. PubMed ID: 25090660
[No Abstract] [Full Text] [Related]
45. Evidence for a change in the epidemiology of hepatitis B virus infection after nearly two decades of universal hepatitis B vaccination in South Africa.
Amponsah-Dacosta E; Lebelo RL; Rakgole JN; Burnett RJ; Selabe SG; Mphahlele MJ
J Med Virol; 2014 Jun; 86(6):918-24. PubMed ID: 24615635
[TBL] [Abstract][Full Text] [Related]
46. Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan.
Chen HL; Chang MH; Ni YH; Hsu HY; Lee PI; Lee CY; Chen DS
JAMA; 1996 Sep; 276(11):906-8. PubMed ID: 8782640
[TBL] [Abstract][Full Text] [Related]
47. Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies.
Ni YH; Huang LM; Chang MH; Yen CJ; Lu CY; You SL; Kao JH; Lin YC; Chen HL; Hsu HY; Chen DS
Gastroenterology; 2007 Apr; 132(4):1287-93. PubMed ID: 17433322
[TBL] [Abstract][Full Text] [Related]
48. Which newborns missed the hepatitis B birth dose vaccination among U.S. children?
Zhao Z; Murphy TV
Prev Med; 2013 Nov; 57(5):613-7. PubMed ID: 23988497
[TBL] [Abstract][Full Text] [Related]
49. Association of vaccine policy with virus infection and awareness of hepatitis B in Fujian, China.
Huang LF; Lin ZQ; Yang XH; Zhang HR; Wang FZ; Wang F; Wu JN; Zhou Y
Hum Vaccin Immunother; 2022 Dec; 18(7):2153535. PubMed ID: 36503415
[TBL] [Abstract][Full Text] [Related]
50. The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization.
Kane MA; Hadler SC; Lee L; Shapiro CN; Cui F; Wang X; Kumar R
Vaccine; 2013 Dec; 31 Suppl 9():J15-20. PubMed ID: 24331015
[TBL] [Abstract][Full Text] [Related]
51. Socioeconomic inequalities in completion of hepatitis B vaccine series among Korean women: results from a nationwide interview survey.
Park B; Choi KS; Lee HY; Jun JK; Park EC
Vaccine; 2012 Aug; 30(40):5844-8. PubMed ID: 22828587
[TBL] [Abstract][Full Text] [Related]
52. Barriers to hepatitis B vaccine coverage among healthcare workers in the Republic of Georgia: An international perspective.
Topuridze M; Butsashvili M; Kamkamidze G; Kajaia M; Morse D; McNutt LA
Infect Control Hosp Epidemiol; 2010 Feb; 31(2):158-64. PubMed ID: 20038247
[TBL] [Abstract][Full Text] [Related]
53. Epidemiological changes in hepatitis B prevalence in an entire population after 20 years of the universal HBV vaccination programme.
Shen LP; Zhang Y; Wang F; Zhang S; Yang JY; Fang KX; Yu T; Wang XY; Zhang WY; Bi SL
Epidemiol Infect; 2011 Aug; 139(8):1159-65. PubMed ID: 21156099
[TBL] [Abstract][Full Text] [Related]
54. Secular trend of the viral genotype distribution in children with chronic hepatitis B virus infection after universal infant immunization.
Wen WH; Chen HL; Ni YH; Hsu HY; Kao JH; Hu FC; Chang MH
Hepatology; 2011 Feb; 53(2):429-36. PubMed ID: 21274864
[TBL] [Abstract][Full Text] [Related]
55. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination.
Williams IT; Goldstein ST; Tufa J; Tauillii S; Margolis HS; Mahoney FJ
Pediatr Infect Dis J; 2003 Feb; 22(2):157-63. PubMed ID: 12586980
[TBL] [Abstract][Full Text] [Related]
56. Clinical characteristics of hepatitis B virus infection in middle school students born after the universal infant vaccination program in Shanghai, China.
Wang WL; Shu ZJ; Zhou LX; Zhao YR
Arch Virol; 2012 May; 157(5):901-5. PubMed ID: 22327392
[TBL] [Abstract][Full Text] [Related]
57. Hepatitis B vaccination in children: the Taiwan experience.
Ni YH; Chen DS
Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
[TBL] [Abstract][Full Text] [Related]
58. Impact of thimerosal-related changes in hepatitis B vaccine birth-dose recommendations on childhood vaccination coverage.
Luman ET; Fiore AE; Strine TW; Barker LE
JAMA; 2004 May; 291(19):2351-8. PubMed ID: 15150207
[TBL] [Abstract][Full Text] [Related]
59. Improved immunization practices reduce childhood hepatitis B infection in Tonga.
Danielsson N; Fakakovikaetau T; Szegedi E
Vaccine; 2009 Jul; 27(33):4462-7. PubMed ID: 19508908
[TBL] [Abstract][Full Text] [Related]
60. Prevalence of hepatitis B surface antigen in vaccinated children and controls in rural Nigeria.
Odusanya OO; Alufohai FE; Meurice FP; Wellens R; Weil J; Ahonkhai VI
Int J Infect Dis; 2005 May; 9(3):139-43. PubMed ID: 15840454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
